Drug development for Alzheimer's disease and dementia is a rapidly evolving field focused on combating cognitive decline and managing symptoms. Researchers target beta-amyloid plaques and tau tangles, pivotal in Alzheimer's pathology, alongside efforts to enhance neurotransmitter function and mitigate brain inflammation. Innovative therapies include monoclonal antibodies to clear amyloid plaques, small molecules targeting tau protein aggregation, and drugs modulating neurotransmitters like acetylcholine. Regenerative strategies such as stem cell therapies aim to repair brain tissue damage. This multifaceted approach aims not only to alleviate symptoms but also to slow or halt disease progression, offering promise for enhancing patients' quality of life in the future.
Jun Hua
Johns Hopkins University , United States
Nazneen N Dewji
Cenna Biosciences Inc, United States
Jacqueline London
Paris Diderot University, FranceSubmit your abstract Today
Title : Neuroimaging-based evaluation of scalp acupuncture for neural repair and reorganization in children with cerebral palsy
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Make a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Health care professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Somali Red Crescent Society, Somalia
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States